Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Kirchheim Unter Teck

9 clinical trials in Kirchheim Unter Teck, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Kirchheim Unter Teck at a glance
9
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

9 trials in Kirchheim Unter Teck

Open in trial search
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:Trustees Of The University Of Pennsylvania
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Methyl-(1-{[6-{[(1S)-1-Cyclopropylethyl]Amino}-2-(Pyrazolo[5,1-B][1,3]Thiazol-7-Yl)-Pyrimidin-4-Yl]Carbonyl}Piperidin-4-Yl)Carbamate-Mono(4-Methylbenzenesulfonate) Monohydrate
  • Sponsor:Ns Pharma Inc.

Colitis ulcerative

Not yet recruiting
Investigational
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Colitis ulcerative

Not yet recruiting
Investigational
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Esk-001
  • Sponsor:Alumis Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Iptacopan
  • Sponsor:Novartis Pharma AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:AstraZeneca AB

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Kirchheim Unter Teck

What the registry says about research in the country

01 Rheumatic and Pulmonary Disorders

Innovative research focusing on lung fibrosis associated with rheumatic diseases, evaluating new therapeutic approaches for improving pulmonary function in patients with systemic autoimmune rheumatic diseases.

  • Interstitial Lung Disease
  • Systemic Autoimmune Conditions
  • Pulmonary Complications

Studies aim to assess treatment effectiveness using advanced imaging techniques and quantitative measurements.

02 Autoimmune Conditions

Clinical investigations targeting lupus nephritis and systemic lupus erythematosus, exploring novel therapeutic agents to improve patient outcomes and achieve disease remission.

  • Lupus Treatment Development
  • Renal Response Assessment
  • Disease Activity Monitoring

Research focuses on evaluating treatment responses and developing targeted therapies for autoimmune manifestations.

03 Inflammatory Diseases

Studies examining treatments for Eosinophilic Granulomatosis with Polyangiitis and ulcerative colitis, comparing various therapeutic approaches to achieve and maintain disease remission.

  • ANCA-Associated Vasculitis
  • Inflammatory Bowel Disease
  • Treatment Efficacy Assessment

Trials aim to establish effective treatment protocols and evaluate long-term disease management strategies.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.